The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration
•A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patc...
Saved in:
Published in: | The veterinary journal (1997) Vol. 208; pp. 90 - 92 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Elsevier Ltd
01-02-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | •A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patch can be safely and effectively used in dogs.
Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1–3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h. |
---|---|
AbstractList | Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h. •A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patch can be safely and effectively used in dogs. Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1–3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h. |
Author | Kang, J.H. Park, H.J. Kim, J.H. Koo, T.S. Choi, Y.J. Song, K.H. Kim, T.H. Seo, K.W. |
Author_xml | – sequence: 1 givenname: J.H. surname: Kim fullname: Kim, J.H. organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 2 givenname: T.H. orcidid: 0000-0003-3237-0244 surname: Kim fullname: Kim, T.H. organization: Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 3 givenname: H.J. surname: Park fullname: Park, H.J. organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 4 givenname: Y.J. surname: Choi fullname: Choi, Y.J. organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 5 givenname: J.H. surname: Kang fullname: Kang, J.H. organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju 362-763, South Korea – sequence: 6 givenname: K.H. surname: Song fullname: Song, K.H. organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 7 givenname: T.S. surname: Koo fullname: Koo, T.S. email: kootae@cnu.ac.kr organization: Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehakro, Daejeon, South Korea – sequence: 8 givenname: K.W. surname: Seo fullname: Seo, K.W. email: kwseo@cnu.ac.kr organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26639828$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kM1u1DAURi3UirYDL8ACecmimfqncRKJDVQUKlXqZvaWY19PPTj2YDtT8QI8EA_CM9XRFJasrv3pu0f2uUAnIQZA6B0la0qouNqty2Hn14zQtgZrQtkrdE5bzho2dPSknslAGsI4P0MXOe8IIcP1NXuNzpgQfOhZf45-bR4B7x9VmpSO312A4nTG0eJS8z-_WaNMghA17EtMWG1jcLlc4jL7OM4FUvSX2AX8GdTWAzZxm7GN3scnF7a4JBWygcr2WAVTizU5VNycsTKTW1hJFRfDG3Rqlc_w9mWu0Ob2y-bmW3P_8PXu5tN9oxljpRlVa8So2MB6TlWneDv2IPp67dSgu9bYTljRGyag7ceOj9ZyTtqhTjuA4Sv04Yjdp_hjhlzk5LIG71WA-ihJOyGqm77qWSF2rOoUc05g5T65SaWfkhK56Jc7ueiXi_4lq_rr0vsX_jxOYP6t_PVdCx-PBaifPDhIMmsHQYNxCXSRJrr_8Z8BQOGczA |
Cites_doi | 10.2332/allergolint.08-OA-0060 10.1620/tjem.212.309 10.1007/BF00316473 10.2332/allergolint.54.283 10.1016/0007-0971(77)90086-9 10.1159/000195176 |
ContentType | Journal Article |
Copyright | 2015 Elsevier Ltd Copyright © 2015 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2015 Elsevier Ltd – notice: Copyright © 2015 Elsevier Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.tvjl.2015.10.012 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 1532-2971 |
EndPage | 92 |
ExternalDocumentID | 10_1016_j_tvjl_2015_10_012 26639828 S1090023315004098 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ AABNK AABVA AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALCJ AALRI AAOAW AAQFI AAQXK AATLK AAXUO ABBQC ABFNM ABGRD ABJNI ABKYH ABLVK ABMAC ABMZM ABRWV ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD ADQTV AEBSH AEKER AENEX AEQOU AESVU AEXOQ AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CBWCG COF CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 QYZTP R2- RIG ROL RPZ SDF SDG SES SEW SNL SPCBC SSA SSH SSZ T5K UHS ~G- ~KM AAHBH AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c222t-ba5d6ba292831a7a35b8e689287a9c75df76f68d26e58b73bff33059bfff9ed3 |
ISSN | 1090-0233 |
IngestDate | Sun Sep 29 08:48:32 EDT 2024 Thu Sep 26 16:38:50 EDT 2024 Sat Sep 28 07:57:42 EDT 2024 Fri Feb 23 02:18:44 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Pharmacokinetics Transdermal patch β2-adrenoceptor agonist Canine Tulobuterol β-adrenoceptor agonist |
Language | English |
License | Copyright © 2015 Elsevier Ltd. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c222t-ba5d6ba292831a7a35b8e689287a9c75df76f68d26e58b73bff33059bfff9ed3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3237-0244 |
PMID | 26639828 |
PQID | 1766266866 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_1766266866 crossref_primary_10_1016_j_tvjl_2015_10_012 pubmed_primary_26639828 elsevier_sciencedirect_doi_10_1016_j_tvjl_2015_10_012 |
PublicationCentury | 2000 |
PublicationDate | February 2016 2016-Feb 2016-02-00 20160201 |
PublicationDateYYYYMMDD | 2016-02-01 |
PublicationDate_xml | – month: 02 year: 2016 text: February 2016 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The veterinary journal (1997) |
PublicationTitleAlternate | Vet J |
PublicationYear | 2016 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Yamaguchi, Nagata, Miyazawa (bib0050) 2005; 54 Hozawa, Haruta, Terada, Yamakido (bib0015) 2009; 58 Uematsu, Nakano, Kosuge, Kanamaru, Nakashima (bib0045) 1993; 44 Nakano, Horiuchi, Fujiwara, Unozawa (bib0025) 1996 Matthys, Daikeler, Krauss, Vastag (bib0020) 1987; 51 Shindoh, Tsushima, Shindoh, Tamura (bib0030) 2007; 212 Tomohiro, Hisatoshi (bib0035) 2013; 2 Turner-Warwick (bib0040) 1977; 71 Matthys (10.1016/j.tvjl.2015.10.012_bib0020) 1987; 51 Nakano (10.1016/j.tvjl.2015.10.012_bib0025) 1996 Shindoh (10.1016/j.tvjl.2015.10.012_bib0030) 2007; 212 Yamaguchi (10.1016/j.tvjl.2015.10.012_bib0050) 2005; 54 Tomohiro (10.1016/j.tvjl.2015.10.012_bib0035) 2013; 2 Hozawa (10.1016/j.tvjl.2015.10.012_bib0015) 2009; 58 Turner-Warwick (10.1016/j.tvjl.2015.10.012_bib0040) 1977; 71 Uematsu (10.1016/j.tvjl.2015.10.012_bib0045) 1993; 44 |
References_xml | – volume: 2 start-page: 9 year: 2013 end-page: 18 ident: bib0035 article-title: Long-term safety, efficacy, and patient acceptability of the tulobuterol patch publication-title: Research and Reports in Transdermal Drug Delivery contributor: fullname: Hisatoshi – volume: 58 start-page: 509 year: 2009 end-page: 518 ident: bib0015 article-title: Effects of the addition of β publication-title: Allergology International contributor: fullname: Yamakido – volume: 54 start-page: 283 year: 2005 end-page: 288 ident: bib0050 article-title: Tulobuterol, a β publication-title: Allergology International contributor: fullname: Miyazawa – volume: 71 start-page: 73 year: 1977 end-page: 86 ident: bib0040 article-title: On observing patterns of airflow obstruction in chronic asthma publication-title: British Journal of Diseases of the Chest contributor: fullname: Turner-Warwick – volume: 44 start-page: 361 year: 1993 end-page: 364 ident: bib0045 article-title: The pharmacokinetics of the β2-adrenoceptor, tulobuterol, given transdermally and by inhalation publication-title: European Journal of Clinical Pharmacology contributor: fullname: Nakashima – volume: 51 start-page: 105 year: 1987 end-page: 112 ident: bib0020 article-title: Action of tulobuterol and fenoterol on the mucociliary clearance publication-title: Respiration; International Review of Thoracic Diseases contributor: fullname: Vastag – year: 1996 ident: bib0025 article-title: Percutaneous preparation of tulobuterol contributor: fullname: Unozawa – volume: 212 start-page: 309 year: 2007 end-page: 317 ident: bib0030 article-title: Transdermal treatment with tulobuterol increases isometric contractile properties of diaphragm muscle in mice publication-title: The Tohoku Journal of Experimental Medicine contributor: fullname: Tamura – volume: 2 start-page: 9 year: 2013 ident: 10.1016/j.tvjl.2015.10.012_bib0035 article-title: Long-term safety, efficacy, and patient acceptability of the tulobuterol patch publication-title: Research and Reports in Transdermal Drug Delivery contributor: fullname: Tomohiro – volume: 58 start-page: 509 year: 2009 ident: 10.1016/j.tvjl.2015.10.012_bib0015 article-title: Effects of the addition of β2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma publication-title: Allergology International doi: 10.2332/allergolint.08-OA-0060 contributor: fullname: Hozawa – year: 1996 ident: 10.1016/j.tvjl.2015.10.012_bib0025 contributor: fullname: Nakano – volume: 212 start-page: 309 year: 2007 ident: 10.1016/j.tvjl.2015.10.012_bib0030 article-title: Transdermal treatment with tulobuterol increases isometric contractile properties of diaphragm muscle in mice publication-title: The Tohoku Journal of Experimental Medicine doi: 10.1620/tjem.212.309 contributor: fullname: Shindoh – volume: 44 start-page: 361 year: 1993 ident: 10.1016/j.tvjl.2015.10.012_bib0045 article-title: The pharmacokinetics of the β2-adrenoceptor, tulobuterol, given transdermally and by inhalation publication-title: European Journal of Clinical Pharmacology doi: 10.1007/BF00316473 contributor: fullname: Uematsu – volume: 54 start-page: 283 year: 2005 ident: 10.1016/j.tvjl.2015.10.012_bib0050 article-title: Tulobuterol, a β2-agonist, attenuates eosinophil adhesion to endothelial cells publication-title: Allergology International doi: 10.2332/allergolint.54.283 contributor: fullname: Yamaguchi – volume: 71 start-page: 73 year: 1977 ident: 10.1016/j.tvjl.2015.10.012_bib0040 article-title: On observing patterns of airflow obstruction in chronic asthma publication-title: British Journal of Diseases of the Chest doi: 10.1016/0007-0971(77)90086-9 contributor: fullname: Turner-Warwick – volume: 51 start-page: 105 year: 1987 ident: 10.1016/j.tvjl.2015.10.012_bib0020 article-title: Action of tulobuterol and fenoterol on the mucociliary clearance publication-title: Respiration; International Review of Thoracic Diseases doi: 10.1159/000195176 contributor: fullname: Matthys |
SSID | ssj0009442 |
Score | 2.1603096 |
Snippet | •A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs... Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 90 |
SubjectTerms | Administration, Cutaneous Administration, Intravenous - veterinary Adrenergic beta-2 Receptor Agonists - blood Adrenergic beta-2 Receptor Agonists - pharmacokinetics Animals Bronchodilator Agents - blood Bronchodilator Agents - pharmacokinetics Canine Dogs - metabolism Pharmacokinetics Random Allocation Terbutaline - analogs & derivatives Terbutaline - blood Terbutaline - pharmacokinetics Transdermal patch Tulobuterol β2-adrenoceptor agonist |
Title | The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration |
URI | https://dx.doi.org/10.1016/j.tvjl.2015.10.012 https://www.ncbi.nlm.nih.gov/pubmed/26639828 https://search.proquest.com/docview/1766266866 |
Volume | 208 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLa67oYbBOOv_MlI7GpLlCZNbF9uJahUAiGtQuMqchK7rFTJxNLxBjwQD8IzcU5tp2nRECBxk7ZHbWL5-3p8bB9_h5CXMEiWIoi5FzDNvVHISk-EgfSKgLOoiIogKXCiODlj7875q3SU9nquOt7G9l-RBhtgjSdn_wLt9qZggPeAOVwBdbj-Me6XVo_6M4SQaxlmmwhwOE4PT2FaKPH4do0JLZhCOa9RPRf7ulkt6xxrPJiyWxfV0amSczxaVc9Rt2G5rL_auhLVVYk-fWnVmxqsYrRWe5Vbarzd2Bdbdo3ZN-YIsNOsQKUoIbpLErbC89Sf-DumWcf03mZ5T_xpaxt_qtfZCR-dza5nDNsUaLfI5g7abLKa0C8HIoAvGs0MXzlfHXqhMBVcnDMPA95xx6YSqR3YTc29X4YMs3qx8JvrBW5FDWMfs_1sbve2FPcZNgNbAVE0OD_B98h-CA4u7pP9kzfp-XQj9zwamX1222x7XMtkFu4-6aaQ6KYpzzr0md0ht-2chZ4Yst0lPVUdkIMPLZT0rU3QuEe-Ach0l3601hToR39836YetdQ7ph3iHdOLihraUaQdbWlHO7SjQDvaoR3dpt19MnudzsYTz5b68AoIUBsvl3GZ5DIUEO0OJZNRnHOVcPjIpChYXGqW6ISXYaJinrMo1zqCkUrAqxaqjB6QflVX6hGhpVAwbgVahxB4KQ7hd6CYBEAgRCuY0ANy5Do7uzSCLpnLdFxkCE2G0KANoBmQ2OGR2ZDUhJoZ0Oe3v3vhwMvAX-MmnKwUdEeGgqwQFPMkGZCHBtW2HWCPBA_543986hNya_OPekr6zZeVekb2rsrVc0vQn4T5wwk |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+pharmacokinetics+of+the+%CE%B22-adrenoceptor+agonist%2C+tulobuterol%2C+in+Beagle+dogs+following+transdermal+and+intravenous+administration&rft.jtitle=The+veterinary+journal+%281997%29&rft.au=Kim%2C+J.H.&rft.au=Kim%2C+T.H.&rft.au=Park%2C+H.J.&rft.au=Choi%2C+Y.J.&rft.date=2016-02-01&rft.pub=Elsevier+Ltd&rft.issn=1090-0233&rft.eissn=1532-2971&rft.volume=208&rft.spage=90&rft.epage=92&rft_id=info:doi/10.1016%2Fj.tvjl.2015.10.012&rft.externalDocID=S1090023315004098 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1090-0233&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1090-0233&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1090-0233&client=summon |